Literature DB >> 15814443

Cognitive impairment in primary and secondary progressive multiple sclerosis.

Ute Wachowius1, Melanie Talley, Nicholas Silver, Hans-Jochen Heinze, Michael Sailer.   

Abstract

The aim of this study was to use neuropsychological data to characterize two subtypes of multiple sclerosis (MS) patients in a large patient sample. We studied patients with primary-progressive MS (PPMS) and secondary-progressive MS (SPMS). A group of 121 MS patients (36 PPS, 85 SPMS) and 40 healthy controls were administered a brief battery of cognitive tests. Executive functioning, memory and attention were studied. Results demonstrate that PPMS patients exhibited slightly more impairment than patients with SPMS, although this difference is not significant (50% vs 37%). However, PPMS patients revealed a significantly poorer performance in verbal learning (p < 0.05) and in verbal fluency (p < 0.05). Whereas PPMS patients had significantly shorter disease durations (p < 0.05), there was no statistical difference in disability between both groups. We conclude from our study that cognitive deficits in progressive MS are frequent. Patients with PPMS tend to be more frequently and severely affected than SPMS patients. Our findings of high prevalence of cognitive involvement in PPMS have not been reported previously

Entities:  

Mesh:

Year:  2005        PMID: 15814443     DOI: 10.1080/138033990513645

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  5 in total

Review 1.  Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.

Authors:  James D Weisfeld-Adams; Ilana B Katz Sand; Justin M Honce; Fred D Lublin
Journal:  Brain       Date:  2015-01-29       Impact factor: 13.501

Review 2.  Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?

Authors:  Christopher Christodoulou; William S MacAllister; Nancy A McLinskey; Lauren B Krupp
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Neuropsychology of multiple sclerosis--an overview.

Authors:  Pasquale Calabrese
Journal:  J Neurol       Date:  2006-02       Impact factor: 4.849

Review 4.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

5.  Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.

Authors:  L Messinis; M H Kosmidis; C Vlahou; A C Malegiannaki; G Gatzounis; N Dimisianos; A Karra; G Kiosseoglou; P Gourzis; P Papathanasopoulos
Journal:  ISRN Neurol       Date:  2013-01-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.